No immune drugs needed: new microtransplant shows promise for frail cancer patients
NCT ID NCT03232268
First seen Mar 22, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study tested a new type of transplant for 25 people with acute myeloid leukemia or myelodysplastic syndromes who could not have a standard bone marrow transplant. Instead of using strong immune-suppressing drugs, doctors gave a small number of blood stem cells from a partially matched family donor. The main goal was to see if this approach could avoid a serious side effect called graft-versus-host disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Paoli Calmettes
Marseille, Bouches du Rhône, 13009, France
Conditions
Explore the condition pages connected to this study.